Literature DB >> 17240236

Fetal thrombocytopenia secondary to parvovirus infection.

Maria Segata1, Rabih Chaoui, Nahla Khalek, Ray Bahado-Singh, Michael J Paidas, Giancarlo Mari.   

Abstract

OBJECTIVE: The aim of this study was to determine the platelet count in fetuses undergoing cordocentesis for hydrops caused by parvovirus infection. STUDY
DESIGN: Fetal platelets were measured at cordocentesis in 11 pregnant women who underwent the procedure because of fetal ascites and/or hydrops caused by parvovirus infection. Thrombocytopenia was defined as mild (platelet count < 150 x 10(9)/L), moderate (platelet count < or = 100 x 10(9)/L), or severe (platelet count to < or = 50 x 10(9)/L). Paired Student t test was performed to compare the platelet count before and after the transfusion.
RESULTS: The fetuses underwent 20 cordocenteses. They were thrombocytopenic in 17 and anemic in 15 occasions. The platelet count was reduced after the transfusion (P < .05). Demises occurred after the first transfusion in 2 fetuses. The first occurred within 5 minutes from the procedure and the second within 24 hours. Both were attributed to exsanguination from the umbilical cord puncture site (platelet count 2 and 24 x 10(9)/L, respectively).
CONCLUSION: Thrombocytopenia is common in fetuses with hydrops caused by parvovirus infection, and can cause exsanguination from the umbilical cord puncture site. We recommend platelet transfusion during cordocentesis when there is severe thrombocytopenia.

Entities:  

Mesh:

Year:  2007        PMID: 17240236     DOI: 10.1016/j.ajog.2006.08.041

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

Review 1.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

2.  Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody.

Authors:  Xiuzhang Xu; Lin Li; Wenjie Xia; Haoqiang Ding; Dawei Chen; Jing Liu; Jing Deng; Yangkai Chen; Zhiming He; Jiali Wang; Yuan Shao; Sentot Santoso; Xin Ye; Qun Fang
Journal:  Int J Hematol       Date:  2017-08-16       Impact factor: 2.490

3.  Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis.

Authors:  Francesca Bonvicini; Chiara Puccetti; Nunzio C M Salfi; Brunella Guerra; Giorgio Gallinella; Nicola Rizzo; Marialuisa Zerbini
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

4.  Intrauterine transfusion in 103 fetuses with severe anemia caused by parvovirus infection. A multicenter retrospective study.

Authors:  Philipp Kosian; Astrid Hellmund; Annegret Geipel; Rainer Bald; Otilia-Maria Geist; Paul Böckenhoff; Jorge Jimenez-Cruz; Maria Deja; Brigitte Strizek; Christoph Berg; Ulrich Gembruch
Journal:  Arch Gynecol Obstet       Date:  2022-08-02       Impact factor: 2.493

5.  A pilot study on parvovirus B19 infection in paediatric haematological malignancies.

Authors:  Janak Kishore; Manodeep Sen; Ashutosh Kumar; Archana Kumar
Journal:  Indian J Med Res       Date:  2011-04       Impact factor: 2.375

6.  Serial intrauterine transfusions for a hydropic fetus with severe anemia and thrombocytopenia caused by parvovirus: lessons learned.

Authors:  Pedro S Argoti; Michael Bebbington; Michael Adler; Anthony Johnson; Kenneth J Moise
Journal:  AJP Rep       Date:  2013-03-19

7.  Molecular Study of Parvovirus B19 Infection in Children withzzm321990Acute Myeloid Leukemia

Authors:  Noha Tharwat Abou El-Khier; Ahmad Darwish; Maysaa El Sayed Zaki
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.